FEDERATED HERMES, INC.

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1056288 PITTSBURGH, PA

Position in CRNX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,957,389

+$3,367,262 QoQ

Shares Held

105,756

+550.9% QoQ

Ownership

0.100%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#78

of 264 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. CRNX ranks #76 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,957,389	105,756	+550.9%	Shares	Defined	2026-08-12
2026-03-31	$590,127	16,248	+3.0%	Shares	Defined	2026-05-11
2024-06-30	$706,247	15,768	+353.5%	Shares	Defined	2024-08-08
2024-03-31	$162,758	3,477	+19216.7%	Shares	Defined	2024-05-14
2023-12-31	$640	18	-25.0%	Shares	Defined	2024-01-31
2023-09-30	$713	24	-99.9%	Shares	Defined	2023-11-13
2022-03-31	$559,329	25,482	+2.6%	Shares	Defined	2022-05-13
2021-12-31	$705,590	24,836	+38706.2%	Shares	Defined	2022-02-14
2020-06-30	$1,121	64	-31.2%	Shares	Defined	2020-08-13
2020-03-31	$1,367	93	—	Shares	Defined	2020-05-13
No filing history on record for this holder in this stock.